Answers are grounded in this paper and cite their sources.
This review summarizes biological production methods for d-tagatose, indicating implications for health and industry.
d-Tagatose, a rare sugar of growing interest, has attracted significant attention due to its low caloric content and associated health benefits. This review summarizes four major biological approaches for d-tagatose production. d-Tagatose can be synthesized from d-galactose either via enzymatic isomerization catalyzed by l-arabinose isomerase or through an oxidoreductive conversion pathway involving galactitol dehydrogenase and xylose reductase. In many cases, β-galactosidase-catalyzed lactose hydrolysis is integrated into the process to provide a cost-effective source of d-galactose. Additionally, several d-tagaturonate 3-epimerases have been identified and engineered to produce D-tagatose from d-fructose via C-4 epimerization. Furthermore, d-tagatose can also be generated from maltodextrin, d-glucose, d-fructose, or sucrose through multienzymatic cascade reactions. This review provides a comprehensive overview of current biotechnological strategies for d-tagatose biosynthesis, offering valuable insights to guide future research and industrial development.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: